Simplex Trading’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3
| Closed | – | – | 9067 |
|
|
2025
Q2 | $0 | Buy |
+3
| New | +$115 | ﹤0.01% | 8639 |
|
|
2024
Q3 | – | Sell |
-35
| Closed | -$1K | – | 8492 |
|
|
2024
Q2 | $1K | Buy |
+35
| New | +$1.27K | ﹤0.01% | 8422 |
|
|
2023
Q3 | – | Sell |
-164
| Closed | -$6K | – | 8685 |
|
|
2023
Q2 | $6K | Buy |
+164
| New | +$6.51K | ﹤0.01% | 7758 |
|
|
2021
Q1 | – | Sell |
-458
| Closed | -$21K | – | 8825 |
|
|
2020
Q4 | $21K | Sell |
458
-2,822
| -86% | -$154K | ﹤0.01% | 6932 |
|
|
2020
Q3 | $203K | Buy |
3,280
+2,187
| +200% | +$140K | ﹤0.01% | 4088 |
|
|
2020
Q2 | $70K | Buy |
1,093
+183
| +20% | +$14.2K | ﹤0.01% | 5167 |
|
|
2020
Q1 | $102K | Buy |
910
+842
| +1,238% | +$96.2K | ﹤0.01% | 4350 |
|
|
2019
Q4 | $7K | Buy |
+68
| New | +$8.75K | ﹤0.01% | 6539 |
|
|
2019
Q3 | – | Sell |
-37
| Closed | -$5K | – | 7240 |
|
|
2019
Q2 | $5K | Buy |
+37
| New | +$5.41K | ﹤0.01% | 6438 |
|
|
2018
Q4 | – | Sell |
-121
| Closed | -$15K | – | 7002 |
|
|
2018
Q3 | $15K | Buy |
121
+76
| +169% | +$10.2K | ﹤0.01% | 6164 |
|
|
2018
Q2 | $7K | Sell |
45
-1,898
| -98% | -$316K | ﹤0.01% | 6518 |
|
|
2018
Q1 | $328K | Buy |
+1,943
| New | +$312K | 0.01% | 945 |
|
|
2017
Q4 | – | Sell |
-13
| Closed | -$2K | – | 5984 |
|
|
2017
Q3 | $2K | Sell |
13
-230
| -95% | -$41.5K | ﹤0.01% | 5004 |
|
|
2017
Q2 | $47K | Buy |
+243
| New | +$53K | ﹤0.01% | 2447 |
|
|
2017
Q1 | – | Sell |
-372
| Closed | -$104K | – | 6138 |
|
|
2016
Q4 | $104K | Buy |
+372
| New | +$102K | 0.01% | 1496 |
|
|
2016
Q3 | – | Sell |
-1,056
| Closed | -$351K | – | 5793 |
|
|
2016
Q2 | $351K | Sell |
1,056
-2,349
| -69% | -$742K | 0.02% | 692 |
|
|
2016
Q1 | $1.19M | Buy |
+3,405
| New | +$1.18M | 0.09% | 187 |
|
|
2015
Q3 | – | Sell |
-804
| Closed | -$184K | – | 5497 |
|
|
2015
Q2 | $184K | Buy |
804
+477
| +146% | +$118K | 0.02% | 839 |
|
|
2015
Q1 | $90K | Buy |
+327
| New | +$100K | 0.01% | 1159 |
|
Other funds holding BIS
CAG
TRCT
Simplex Trading's BIS Position: Q3 2025 in Review
Simplex Trading sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2025, closing a stake of 3 shares.
Simplex Trading first reported a position in BIS in Q1 2015 and held it in 19 quarters. The position peaked at $1.19M in Q1 2016. 4 funds tracked by Wall St. Rank hold BIS as of Q3 2025.
- Simplex Trading reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 3 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2025.
- Simplex Trading first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q1 2015 and held it in 19 quarters.
- Simplex Trading's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.19M in Q1 2016.
- 4 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.